Antinucleosome antibodies in primary antiphospholipid syndrome: A hint at systemic autoimmunity?

Journal of Autoimmunity

Volumn 30, Issue 1-2, 2008, Pages 51-57

  Andreoli, Laura ^a   Pregnolato, Francesca ^b   Burlingame, Rufus W ^c   Allegri, Flavio ^a   Rizzini, Silvia ^a   Fanelli, Valentina ^b   Radice, Antonella ^d   Corace, Caterina ^e   Sinico, Renato Alberto ^e   Meroni, Pier Luigi ^b   Tincani, Angela ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c INOVA DIAGNOSTICS INC   (United States)

^d SAN CARLO BORROMEO HOSPITAL   (Italy)

^e Clinical Immunology and Rheumatology Unit   (Italy)

Author keywords

Anti chromatin antibodies; Antinucleosome antibodies; Primary antiphospholipid syndrome; Systemic lupus erythematosus

Indexed keywords

NUCLEOSOME ANTIBODY;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNITY; CHROMATIN; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HUMAN; LUPUS LIKE SYNDROME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; COHORT STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NUCLEOSOMES;

EID: 38049072128     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.11.004     Document Type: Article

References (53)

1. Burlingame R.W. Recent advances in understanding the clinical utility and underlying cause of antinucleosome (antichromatin) autoantibodies. Clin Appl Immunol Rev 4 (2004) 351-366
2. Burlingame R.W., Boey M.L., Starkebaum G., and Rubin R.L. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 94 (1994) 184-192
3. Chabre H., Amoura Z., Piette J.-C., Godeau P., Bach J.-F., and Koutouzov S. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 38 (1995) 1485-1491
4. Cervera R., Viňas O., Ramos-Casals M., Font J., Garcia-Carrasco M., Siso A., et al. Antichromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis 62 (2003) 431-434
5. Ravirajan C.T., Rowse L., MacGowan J.R., and Isenberg D.A. An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatology (Oxford) 40 (2001) 1404-1412
6. Amoura Z., Koutouzov A., Chabre H., Cacoub P., Amoura I., Musset L., et al. Presence of antinucleosome antibodies in a restricted set of connective tissue diseases. Arthritis Rheum 43 (2000) 76-84
7. Min D.J., Kim S.J., Park S.H., Seo Y.I., Kang H.J., Kim W.U., et al. Antinucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody. Clin Exp Rheumatol 20 (2002) 13-18
8. Ghillani-Dalbin P., Amoura Z., Cacoub P., Charuel J.-L., Diemert M.-C., Piette J.-C., et al. Testing for antinucleosome antibodies in daily practice: a monocentric evaluation in 1696 patients. Lupus 12 (2003) 833-837
9. Ng K.P., Manson J.J., Rahman A., and Isenberg D.A. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescient with systemic lupus erythematosus. Arthritis Rheum 55 (2006) 900-904
10. Kramers C., Hylkema M.N., van Bruggen M.C., van de Lagemaat R., Dijkman H.B., Assmann K.J., et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 94 (1994) 568-577
11. Burlingame R.W., Rubin R.L., Balderas R.S., and Theofilopoulos A.N. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 91 (1993) 1687-1696
12. Amoura Z., Chabre H., Koutouzov S., Lotton C., Cabrespines A., Bach J.-F., et al. Nucleosome restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 37 (1994) 1684-1688
13. Hughes G. The anticardiolipin syndrome. Clin Exp Rheumatol 25 (1985) 285-286
14. Alarcón-Segovia D., and Sánchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 16 (1989) 482-488
15. Piette J.-C., Wechsler B., Frances C., Papo T., and Godeau P. Exclusion criteria for primary antiphospholipid syndrome. J Rheumatol 20 (1993) 1802-1803
16. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725-1734
17. Shoenfeld Y. APS - more systemic disease than SLE. Clin Rev Allergy Immunol 32 (2007) 129-130
18. Holers V.M., Girardi G., Mo L., Guthridge J.M., Molina H., Vilpando C.G., et al. Complement C3 activation is required for anti-phospholipid antibody-induced fetal loss. J Exp Med 195 (2002) 211-220
19. Fischetti F., Durigotto P., Pellis V., Debeus A., Macor P., Bulla R., et al. Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. Blood 106 (2005) 2340-2346
20. Seisedos L., Muňoz-Rodríguez J., Cervera R., Font J., and Ingelmo M. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. Lupus 6 (1997) 285-286
21. Gomez-Puerta J.A., Martin H., Amigo M.C., Aguirre M.A., Camps M.T., Cuadrado M.J., et al. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?. Medicine (Baltimore) 84 (2005) 225-230
22. Tarr T., Lakos G., Bhattoa H.P., Szegedi G., Shoenfeld Y., and Kiss E. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus. Lupus 16 (2007) 324-328
23. Simón J.A., Rojas-Serrano J., Cabiedes J., and Alcocer-Varela J. Antinucleosome antibodies may help predict development of systemic lupus erythematosus in patients with primary antiphospholipid syndrome. Lupus 13 (2004) 177-181
24. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2006) 295-306
25. Tincani A., Allegri F., Sanmarco M., Cinquini M., Taglietti M., Balestrieri G., et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determination - an operative project of the European Antiphospholipid Forum. Thromb Haemost 86 (2001) 575-583
26. 2glycoprotein I antibodies. A marker of antiphospholipid syndrome?. Lupus 4 (1995) 122-130
27. Brandt J.T., Barna L.K., and Triplett D.A. Laboratory identification of lupus anticoagulants: results of the Second International Workshop for identification of lupus anticoagulants. On behalf of the Subcommittee on lupus anticoagulants/antiphospholipid antibodies of the ISTH. Thromb Haemost 74 (1995) 1597-1603
28. Pincus T., Schur P.H., Rose J.A., Decker J.L., and Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Eng J Med 281 (1969) 701-705
29. Bernstein R.M., Bunn C.C., and Hughes G.R.V. Identification of autoantibodies to acid antigens by counterimmunoelectrophoresis. Ann Rheum Dis 41 (1982) 554-555
30. Meroni P.L., Ronda N., De Angelis V., Grossi C., Raschi E., and Borghi M.O. Role of anti-beta2 glycoprotein I antibodies in antiphospholipid syndrome: in vitro and in vivo studies. Clin Rev Allergy Immunol 32 (2007) 67-74
31. Salmon J.E., and Girardi G. Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation. J Reprod Immunol (2007) [Epub ahead of print]
32. Cervera R., Piette J.-C., Font J., Khamashta M.A., Shoenfeld Y., Camps M.T., et al. Antiphospholipid syndrome: clinical and immunological manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46 (2002) 1019-1027
33. Manfredi A.A., Rovere P., Heltai S., Galati G., Nebbia G., Tincani A., et al. Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein I. Arthritis Rheum 41 (1998) 215-223
34. Manfredi A.A., Rovere P., Galati G., Heltai S., Bozzolo E., Soldini L., et al. Apoptotic cell clearance in systemic lupus erythematosus. I. opsonization by antiphospholipid antibodies. Arthritis Rheum 41 (1998) 205-214
35. Pascual V., Farkas L., and Banchereau J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol 18 (2006) 676-682
36. Abraham M., Karni A., Dembinsky A., Miller A., Gandhi R., Anderson D., et al. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. J Autoimmun 30 (2008) 21-28
37. Asherson R.A. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS"). Autoimmun Rev 6 (2006) 76-80
38. Asherson R.A. The catastrophic antiphospholipid (Asherson's) syndrome. Autoimmun Rev 6 (2006) 64-67
39. Binard A., Le Pottier L., Saraux A., Devauchelle-Pensec V., Pers J.-O., and Youinou P. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?. J Autoimmun 30 (2008) 63-67
40. Cervera R., Espinosa G., Bucciarelli S., Gómez-Puerta JA., and Font J. Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry. Autoimmun Rev 6 (2006) 81-84
41. Gleicher N., and Barad D.H. Gender as risk factor for autoimmune diseases. J Autoimmun 28 (2007) 1-6
42. Jacobson E., Huber A., and Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 30 (2008) 58-62
43. Kallenberg C. Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 30 (2008) 29-36
44. Mackay I., Leskovek N., and Rose N. Cell damage and autoimmunity: a critical appraisal. J Autoimmun 30 (2008) 5-11
45. Makatsariya A., Asherson RA., Bitsadze V., Baimuradova S., and Akinshina S. Catastrophic antiphospholipid (Asherson's) syndrome and genetic thrombophilic disorders in obstetrics. Autoimmun Rev. 6 (2006) 89-93
46. Nakanishi Y., Tsuneyama K., Fujimoto M., Thucydides L., Nomoto K., An J.-L., et al. Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. J Autoimmun 30 (2008) 42-50
47. Poletaev A., Stepanyuk V., and Gershwin M. Integrating immunity: the immunculus and self reactivity. J Autoimmun 30 (2008) 68-73
48. Praprotnik S., Sodin-Semrl S., Tomsic M., and Shoenfeld Y. The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J Autoimmun 30 (2008) 37-41
49. Recalcati S., Invernizzi P., Arosio P., and Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 30 (2008) 84-89
50. Sanchez-Pernaute O., Ospelt C., Neidhart M., and Gay S. Epigenetic clues to rheumatoid arthritis. J Autoimmun 30 (2008) 12-20
51. Shoenfeld Y., and Gershwin M. Autoimmunity: from the mosaic to the kaleidoscope. J Autoimmun 30 (2008) 1-4
52. Wu J.F., Yang YH., Wang LC., Lee JH., Shen EY., and Chiang BL. Antinucleosome antibodies correlate with the disease severity in children with systemic lupus erythematosus. J Autoimmun 27 (2006) 119-124
53. Youinou P. B cell conducts the lymphocyte orchestra. J Autoimmun 28 (2007) 143-151